Moderna reported mixed fourth quarter earnings and full-year 2024 earnings Friday. Moderna's stock was down 5% in premarket ...

The Trump administration’s delay of what was supposed to be this week’s regularly scheduled meeting of the CDC’s vaccine ...

The FDA is mired in uncertainty with some staffers losing their jobs over the weekend and more potentially to come, vaccines ...

Thousands of U.S. health agency employees were terminated and told it was for poor performance, though they'd received strong ...

Moderna reported mixed fourth quarter earnings and full-year 2024 earnings Friday. Moderna's stock was down 4.5% in premarket trading on the earnings results. Moderna reported $96 ...

MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...

Moderna stock tumbled after the Senate Finance Committee voted to send RFK Jr.'s nomination for the HHS secretary to the full chamber.

Without further ado, let's jump right in. The U.S. Department of Health and Human Services (HHS) had already granted Moderna another $176 million back in July 2024. This is mostly focused on the ...

A personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study ...

There is also concern about how Moderna will operate under a new administration in Washington with the confirmation of Robert F. Kennedy Jr. at the helm of the Health and Human Services (HHS ...

According to HHS, the funding will enable Moderna to streamline a vaccine that is “well matched to strains currently circulating in cows and birds,” and expand data on the use of mRNA vaccines ...

Are [children] supposed to just die or get sick because their parents don't have the funds to get the vaccines for them?' a nurse practitioner asks.